Fuse develops and manufactures innovative diagnostic products for a range of industries delivering lab quality information wherever it is needed through ultra-rapid, low-cost tests. The immunoassay and PCR technologies that dominate the diagnostics industry have consistently failed to deliver lab-quality tests that are suitable for widespread decentralised use. Using an all-new multianalytic chemistry and breakthrough product innovations Fuse has overcome the cost and performance challenges of established approaches to make accurate, point-of-need testing a reality for all.
| Website | https://www.fuse-dx.com |
| Employees | 12 (9 on RocketReach) |
| Industry | Manufacturing |
| Keywords | Rapid Diagnostic Tests, Point Of Care Diagnostics, Low Cost Diagnostics, Pcr Technology, Diagnostic Devices, Medical Diagnostics, In Vitro Diagnostics, Diagnostic Tools, Molecular Diagnostics, Diagnostic Solutions, Healthcare Diagnostics, Portable Diagnostics, Convenient Diagnostics, Affordable Diagnostics, Onsite Diagnostics, Lateral Flow Assays, Diagnostic Manufacturing |
| Competitors | Siemens Healthineers, Roche, Thermo Fisher Scientific, Abbott, BD, Quest Diagnostics, Hologic, Inc., Illumina, Cepheid, Bio-Rad Laboratories +43 more (view full list) |
Looking for a particular Fuse Diagnostics employee's phone or email?
Harry Lamble is the CEO of Fuse Diagnostics.
9 people are employed at Fuse Diagnostics.
Fuse Diagnostics is based in Cambridge, England.